Finance

Lists
603676:SHA
Xizang Weixinkang Pharmaceutical Co Ltd
8,77 CNY
-0,68%
(-0,060) 1D
16 ოქტ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603676...
Open
8,96 CNY
High
9,06 CNY
Low
8,72 CNY
Mkt. cap
3,91 მლრდ.
Avg. vol.
1,57 მლნ.
Volume
1,84 მლნ.
Dividend
3,73%
Quarterly dividend
0,08 CNY
Ex-dividend date
29 ივნ. 2026
P/E ratio
19,68
52-wk high
12,08 CNY
52-wk low
7,82 CNY
EPS
0,45 CNY
Shares outstanding
423,00 მლნ.
No. of employees
763
Open
8,96 CNY
High
9,06 CNY
Low
8,72 CNY
Mkt. cap
3,91 მლრდ.
Avg. vol.
1,57 მლნ.
Volume
1,84 მლნ.
Dividend
3,73%
Quarterly dividend
0,08 CNY
Ex-dividend date
29 ივნ. 2026
P/E ratio
19,68
52-wk high
12,08 CNY
52-wk low
7,82 CNY
EPS
0,45 CNY
Shares outstanding
423,00 მლნ.
No. of employees
763
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
12 წუთის წინ
Phase 3 Lung Trials Could Be A Big Test For Insmed (INSM)
Law360
Law360
·
1 საათის წინ
Nasdaq Sued Over Delisting Of Social Media Co.
Yahoo Finance
Yahoo Finance
·
46 წუთის წინ
Dow (DOW) Stock Could Look Reasonable After a 43% Gain
Seeking Alpha
Seeking Alpha
·
1 საათის წინ
S&P 500 Snapshot: Stocks Slide Nearly 2% For The Week
About Xizang Weixinkang Pharmaceutical Co Ltd
CEO-
Employees763
Founded2002
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
276,24 მლნ.
273,33 მლნ.
322,14 მლნ.
262,14 მლნ.
Cost of goods sold
103,31 მლნ.
113,44 მლნ.
128,24 მლნ.
109,51 მლნ.
Cost of revenue
103,31 მლნ.
113,44 მლნ.
128,24 მლნ.
109,51 მლნ.
Research and development expenses
28,10 მლნ.
34,04 მლნ.
19,29 მლნ.
20,63 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85,75 მლნ.
111,67 მლნ.
93,39 მლნ.
87,12 მლნ.
Operating expense
81,29 მლნ.
180,88 მლნ.
116,61 მლნ.
110,23 მლნ.
Total operating expenses
184,60 მლნ.
294,32 მლნ.
244,85 მლნ.
219,74 მლნ.
Operating income
91,65 მლნ.
-20,98 მლნ.
77,29 მლნ.
42,40 მლნ.
Other non operating income
10,90 ათ.
-224,74 ათ.
7,57 ათ.
-160,84 ათ.
EBT including unusual items
60,67 მლნ.
15,41 მლნ.
80,30 მლნ.
86,94 მლნ.
EBT excluding unusual items
95,80 მლნ.
-17,48 მლნ.
80,14 მლნ.
45,64 მლნ.
Income tax expense
24,28 მლნ.
1,73 მლნ.
11,96 მლნ.
12,35 მლნ.
Effective tax rate
40,02%
11,24%
14,89%
14,21%
Other operating expenses
-32,87 მლნ.
36,84 მლნ.
3,07 მლნ.
2,08 მლნ.
Net income
36,39 მლნ.
13,68 მლნ.
68,34 მლნ.
74,59 მლნ.
Net profit margin
13,17%
5,00%
21,21%
28,45%
Earnings per share
-
-
-
-
Interest and investment income
4,35 მლნ.
3,80 მლნ.
2,94 მლნ.
3,44 მლნ.
Interest expense
-84,28 ათ.
-58,13 ათ.
-98,46 ათ.
-53,47 ათ.
Net interest expenses
4,27 მლნ.
3,74 მლნ.
2,84 მლნ.
3,39 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
103,26 მლნ.
-10,17 მლნ.
88,10 მლნ.
53,19 მლნ.
Gain or loss from assets sale
88,96 ათ.
80,57 ათ.
-
4,48 ათ.
AI content may include mistakes. Learn more
Google აპები